Compare RBC & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RBC | BAX |
|---|---|---|
| Founded | 1919 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.6B | 9.4B |
| IPO Year | 2005 | N/A |
| Metric | RBC | BAX |
|---|---|---|
| Price | $443.24 | $18.54 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 10 |
| Target Price | ★ $441.17 | $25.67 |
| AVG Volume (30 Days) | 165.1K | ★ 8.3M |
| Earning Date | 10-31-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 0.22% |
| EPS Growth | ★ 19.54 | N/A |
| EPS | ★ 8.20 | N/A |
| Revenue | $1,723,400,000.00 | ★ $11,023,000,000.00 |
| Revenue This Year | $14.65 | $5.20 |
| Revenue Next Year | $10.87 | $2.02 |
| P/E Ratio | $54.08 | ★ N/A |
| Revenue Growth | ★ 8.27 | 3.90 |
| 52 Week Low | $290.56 | $17.40 |
| 52 Week High | $449.60 | $37.74 |
| Indicator | RBC | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 63.56 | 43.20 |
| Support Level | $431.72 | $18.33 |
| Resistance Level | $448.31 | $19.17 |
| Average True Range (ATR) | 10.45 | 0.54 |
| MACD | -0.71 | 0.21 |
| Stochastic Oscillator | 79.84 | 63.23 |
RBC Bearings Inc is an international manufacturer and marketer of engineered precision bearings, components, and essential systems for the industrial, defense, and aerospace industries. The offering includes plain bearings, roller bearings, ball bearings, and engineered products. The company has two reportable segments: Industrial, which derives maximum revenue, and Aerospace/Defense. The Aerospace/Defense segment represents the end markets for the company's engineered bearings and precision components used in commercial aerospace, defense aerospace, and sea and ground defense applications; and the Industrial segment represents the end markets for its products used in various industrial applications. Geographically, the company generates a majority of its revenue from the United States.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.